These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12510569)

  • 21. K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials.
    Miller MD; Margot N; McColl D; Cheng AK
    AIDS; 2007 Jan; 21(2):265-6. PubMed ID: 17197831
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategies for highly treatment-experienced HIV-infected patients.
    Luber AD
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):815-23. PubMed ID: 16207173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring in HIV disease.
    Hoetelmans R; Miller V
    J HIV Ther; 2001 Aug; 6(3):65-7. PubMed ID: 11547263
    [No Abstract]   [Full Text] [Related]  

  • 25. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral drug trials.
    Van Rompay KK; Marthas ML
    Science; 1997 Jun; 276(5318):1482-4. PubMed ID: 9190679
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefits and concerns of simplification strategies in HIV-infected patients.
    Negredo E; Bonjoch A; Clotet B
    J Antimicrob Chemother; 2006 Aug; 58(2):235-42. PubMed ID: 16807250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opportunities and options for treatment research in resource-constrained settings.
    Volberding PA
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S1-3. PubMed ID: 12822126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tenofovir on didanosine absorption in patients with HIV.
    Pecora Fulco P; Kirian MA
    Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Running with scissors: using antiretroviral therapy without monitoring viral load.
    Smith DM; Schooley RT
    Clin Infect Dis; 2008 May; 46(10):1598-600. PubMed ID: 18419496
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequency of medical history items, drug interactions, and lifestyle characteristics that may interfere with antiretroviral medications.
    Grimes RM; Lal L; Lewis ST
    HIV Clin Trials; 2002; 3(2):161-7. PubMed ID: 11976995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions. Introduction: careful combinations.
    TreatmentUpdate; 2006; 18(3):1-2. PubMed ID: 17209235
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment: fixed-dose combination formulations are the answer, what was the question?
    Pavia AT
    AIDS Read; 2004 Oct; 14(10):549. PubMed ID: 15510391
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of recent guidelines for antiretroviral treatment of HIV-infected children.
    Oleske JM
    Top HIV Med; 2003; 11(6):180-4. PubMed ID: 14724326
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiretroviral therapy of HIV infection. German-Austrian recommendations (July 2002).
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Eur J Med Res; 2003 Jun; 8(6):257-74. PubMed ID: 12918533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.